Catalyst Pharmaceuticals Inc Cash Flow Reinvestment Rate
Catalyst Pharmaceuticals Inc cash flow reinvestment rate. Catalyst Pharmaceuticals Inc (CPRX) has a Cash Flow Reinvestment Rate of 0.00x as of March 2026, reinvesting $27.00K (capex $27.00K ) from operating cash flow of $59.59 Million. Explore debt repayment capacity of Catalyst Pharmaceuticals Inc to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Catalyst Pharmaceuticals Inc (2019–2025)
Cash flow reinvestment rate of Catalyst Pharmaceuticals Inc from 2019 to 2025. Historical reinvestment intensity for Catalyst Pharmaceuticals Inc across 7 annual periods. Explore Catalyst Pharmaceuticals Inc capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Catalyst Pharmaceuticals Inc Cash Flow Reinvestment Rate by Year (2019–2025)
Catalyst Pharmaceuticals Inc cash flow reinvestment rate by year from 2019 to 2025. Year-by-year capital reinvestment analysis for Catalyst Pharmaceuticals Inc. For the full cash flow conversion analysis, see CPRX cash flow metrics.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.00x | $58.00K | $208.67 Million | $58.00K | ▼ -94.0% |
| 2024 | 0.00x | $1.11 Million | $239.81 Million | $556.00K | ▼ -99.8% |
| 2023 | 2.35x | $336.93 Million | $143.60 Million | $81.74 Million | ▲ +1313.2% |
| 2022 | 0.17x | $19.27 Million | $116.05 Million | $29.00K | ▼ -9.1% |
| 2021 | 0.18x | $11.02 Million | $60.37 Million | $1.02 Million | ▲ +63.7% |
| 2020 | 0.11x | $5.02 Million | $45.03 Million | $11.39K | ▼ -89.6% |
| 2019 | 1.08x | $37.26 Million | $34.61 Million | $19.37K | — |